On November 11, 1987, Jooji, Eru Euansu; Debora, Eru Deuookusu published a patent.Application In Synthesis of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate The title of the patent was Pathogenic Neisseria-specific growth medium and its use in clinical diagnosis. And the patent contained the following:
A medium containing vancomycin (I) and lincomycin (II) for selectively growing Neisseria is prepared Its use in clin. diagnosis of pathogenic Neisseria such as N. gonorrhoeae or N. meningitidis is also disclosed. An agar medium containing GC agar base 36.0, Hb 10.0 g/L, Isovitalex enrichment 10.0 mL/L, I 2.0 mg/L, II 1.0, colistin sulfate 7.5, trimethoprim 5.0, amphotericin B 5.0 μg/L, and nystatin 1250 units/L was prepared and tested for its selectivity. The growth of N. gonorrhoeae and N. meningitidis was excellent while growth of other microorganisms such as yeast was inhibited. The experimental process involved the reaction of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate(cas: 23256-42-0).Application In Synthesis of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate
The Article related to neiserria pathogen selection culture medium, vancomycin lincomycin neiserria pathogen selection, Fermentation and Bioindustrial Chemistry: Methods (Including Analysis) and other aspects.Application In Synthesis of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate
Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia